An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
Clinical trial NCT01009281 · TERMINATED
Trial details
- NCT number
- NCT01009281
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-30
- Primary completion
- 2010-08-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.